A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma.

Iaboni, Aled; Wong, Natalie; Betschel, Stephen D

Iaboni, Aled; Wong, Natalie; Betschel, Stephen D.

Iaboni A; Department of Internal Medicine, Division of Clinical Immunology and Allergy, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. aled.iaboni@unityhealth.to.
Wong N; Department of Critical Care, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
Betschel SD; Division of Clinical Immunology and Allergy, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.

J Clin Immunol ; 41(5): 923-925, 2021 07.

Article in English | MEDLINE | ID: covidwho-1064556

Subject(s)

Adenosine Monophosphate/analogs & derivatives; Agammaglobulinemia/complications; Alanine/analogs & derivatives; COVID-19/therapy; Genetic Diseases, X-Linked/complications; Adenosine Monophosphate/therapeutic use; Adult; Alanine/therapeutic use; Humans; Immunization, Passive; Male; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Adenosine Monophosphate / Agammaglobulinemia / Genetic Diseases, X-Linked / Alanine / COVID-19 Type of study: Case report Topics: Long Covid Limits: Adult / Humans / Male Language: English Journal: J Clin Immunol Year: 2021 Document Type: Article Affiliation country: S10875-021-00983-y

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google